TG THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
TG THERAPEUTICS, INC. (TGTX) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $96.67 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2026-02-27
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $96.67M.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $103.69M.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $47.61M.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $25.06M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value |
|---|---|
| 2025-12-31 | $96.67M 10-K · filed 2026-02-27 |
| 2024-12-31 | $103.69M 10-K · filed 2026-02-27 |
| 2023-12-31 | $47.61M 10-K · filed 2026-02-27 |
| 2022-12-31 | $25.06M 10-K · filed 2026-02-27 |
| 2021-12-31 | $29.50M 10-K · filed 2025-03-03 |
| 2020-12-31 | $115.47M 10-K · filed 2024-02-29 |
| 2019-12-31 | $11.71M 10-K · filed 2023-03-01 |
| 2019-09-30 | $1.85B 10-Q · filed 2019-11-12 |
| 2019-06-30 | $5.68M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $5.80B 10-Q · filed 2019-05-10 |
| 2018-12-31 | $0.00 10-Q · filed 2019-11-12 |
| 2018-09-30 | $0.00 10-Q · filed 2018-11-09 |
| 2018-06-30 | $897.25M 10-Q · filed 2018-08-09 |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-11 |
| 2014-12-31 | $0.00 10-Q · filed 2015-05-11 |
| 2014-09-30 | $81.51K 10-Q · filed 2014-11-14 |
| 2014-06-30 | $229.54K 10-Q · filed 2014-07-24 |
| 2014-03-31 | $115.00K 10-Q · filed 2014-05-14 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-16 |
| 2013-09-30 | $29.44K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $91.54K 10-Q · filed 2013-08-09 |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-14 |
| 2012-12-31 | $0.00 10-Q · filed 2013-11-14 |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-14 |
| 2012-06-30 | $0.00 10-Q/A · filed 2012-09-07 |
| 2011-12-31 | $0.00 10-K · filed 2014-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |